Mutual pharmacokinetic interactions between steady-state bosentan and sildenafil

被引：0
|
作者：
Gary Burgess
Hans Hoogkamer
Lorraine Collings
Jasper Dingemanse
机构：
[1] PGRD,
[2] Pfizer Ltd,undefined
[3] Actelion Pharmaceuticals Ltd,undefined
来源：
European Journal of Clinical Pharmacology | 2008年 / 64卷
关键词：
Bosentan; Combination therapy; Pharmacokinetics; Sildenafil;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：43 / 50
页数：7
相关论文
共 50 条
  • [1] Mutual pharmacokinetic interactions between steady-state bosentan and sildenafil
    Burgess, Gary
    Hoogkamer, Hans
    Collings, Lorraine
    Dingemanse, Jasper
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 64 (01) : 43 - 50
  • [2] Mutual pharmacokinetic interactions between bosentan and Iopinavir/ritonavir in healthy participants
    Dingemanse, Jasper
    van Giersbergen, Paul L. M.
    Patat, Alain
    Nilsson, Per N.
    ANTIVIRAL THERAPY, 2010, 15 (02) : 157 - 163
  • [3] Lack of pharmacokinetic interactions between steady-state zonisamide and valproic acid in patients with epilepsy
    Ragueneau-Majlessi, I
    Levy, RH
    Brodie, M
    Smith, D
    Shah, J
    Grundy, JS
    CLINICAL PHARMACOKINETICS, 2005, 44 (05) : 517 - 523
  • [4] Lack of Pharmacokinetic Interactions Between Steady-State Zonisamide and Valproic Acid in Patients with Epilepsy
    Isabelle Ragueneau-Majlessi
    Rene H. Levy
    Martin Brodie
    David Smith
    Jaymin Shah
    John S. Grundy
    Clinical Pharmacokinetics, 2005, 44 : 517 - 523
  • [5] STEADY-STATE INVESTIGATION OF POSSIBLE PHARMACOKINETIC INTERACTIONS OF MOXONIDINE AND GLIBENCLAMIDE
    MULLER, M
    WEIMANN, HJ
    EDEN, G
    WEBER, W
    MICHAELIS, K
    DILGER, C
    ACHTERT, G
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1993, 18 (03) : 277 - 283
  • [6] Investigation of the mutual pharmacokinetic interactions between bosentan, a dual endothelin receptor antagonist, and simvastatin
    Dingemanse, J
    Schaarschmidt, D
    van Giersbergen, PLM
    CLINICAL PHARMACOKINETICS, 2003, 42 (03) : 293 - 301
  • [7] Investigation of the mutual pharmacokinetic interactions between bosentan, a dual endothelin receptor antagonist, and simvastatin
    Dingemanse, J
    Schaarschmidt, D
    Van Giersbergen, PLM
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 53 (05) : 547P - 547P
  • [8] Investigation of the Mutual Pharmacokinetic Interactions Between Bosentan, a Dual Endothelin Receptor Antagonist, and Simvastatin
    Jasper Dingemanse
    Dieter Schaarschmidt
    Paul L. M. van Giersbergen
    Clinical Pharmacokinetics, 2003, 42 : 293 - 301
  • [9] Investigation of Potential Pharmacokinetic Interactions Between Teneligliptin and Metformin in Steady-state Conditions in Healthy Adults
    Nakamaru, Yoshinobu
    Hayashi, Yoshiharu
    Davies, Martin
    Heuer, Horst Juergen
    Hisanaga, Noriko
    Akimoto, Kei
    CLINICAL THERAPEUTICS, 2015, 37 (09) : 2007 - 2018
  • [10] In Vitro P-Glycoprotein Interactions and Steady-State Pharmacokinetic Interactions Between Tolvaptan and Digoxin in Healthy Subjects
    Shoaf, Susan E.
    Ohzone, Yoshihiro
    Ninomiya, Shin-ichi
    Furukawa, Masayuki
    Bricmont, Patricia
    Kashiyama, Eiji
    Mallikaarjun, Suresh
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (05): : 761 - 769
12345